Noile-Immune Biotech News

Noile-Immune Biotech: (Correction) Partial Corrections to the “Notice Concerning the Recording of Non-operating Income”

Nov 18 17:00

Noile-Immune Biotech: Notice Concerning the Recording of Non-Operating Profit

Nov 14 14:30

Noile-Immune Biotech: (Correction) Partial Corrections to the “Notice Concerning Prioritization of Our Drug Discovery Pipeline and Associated Changes in the Use of Funds Raised at the Time of Listing”

Oct 11 16:00

Noile-Immune Biotech: Notice regarding a business alliance with Takara Bio Co., Ltd. for the development of NIB103

Sep 25 14:00

Noile-Immune Biotech: Announcements of individual stocks regarding the re-prioritization of our in-house drug development pipeline and changes in the use of funds raised at the time of listing.

Jun 28 16:00

Noile-Immune Biotech: Regarding the return of NIB102 and NIB103 to Takeda Pharmaceutical.

Jun 24 08:12

Noile-Immune Biotech: Matters relating to business plans and growth potential

Mar 29 15:30

Noile-Immune Biotech: Independent Officer Notification Form

Mar 13 16:00

Noile-Immune Biotech: [Delayed]Supplemental Comments on the Termination of the License Agreements for NIB102 and NIB103

Dec 18, 2023 12:00

Noile-Immune Biotech: Announcement on the Termination of License Agreement for NIB102 and NIB103

Dec 15, 2023 18:45

Noile-Immune Biotech: Additional comments on the cancellation of the NIB102 and NIB103 license agreements

Dec 15, 2023 18:45

Noile-Immune Biotech: Notice Concerning Cancellation of NIB102 and NIB103 License Agreements

Dec 15, 2023 18:45

Noile-Immune Biotech: Achievement of milestones related to the license agreement with Chugai Pharmaceutical

Sep 6, 2023 16:30

Noile-Immune Biotech: About the partnership between Sysmex and Neulimune Biotech on technology to optimize the function of CAR-T cells

Jul 31, 2023 15:00

Noile-Immune Biotech: Articles of Incorporation 2022/11/21

Jun 28, 2023 12:20

Noile-Immune Biotech: Independent Officer Notification Form

Jun 28, 2023 11:30

Noile-Immune Biotech: Matters relating to business plans and growth potential

Jun 28, 2023 07:00

Noile-Immune Biotech: Notice regarding changes in other affiliated companies

Jun 28, 2023 07:00

Noile-Immune Biotech: Notice of our financial results information etc. associated with listing on the Tokyo Stock Exchange Growth Market

Jun 28, 2023 07:00

Noile-Immune Biotech: Confirmation of the appropriateness of securities reports, etc. for listing applications

May 25, 2023 16:00